The epidemic of abuse of the so-called 'designer drugs' amphetamine, cocain
e and ecstasy-is fast replacing traditional aetiological factors as the lar
gest cause of intracerebral haemorrhage among young adults. Traditional tea
ching is that these represent hypertensive haemorrhages. Recent reports, ho
wever, have indicated that these patients may harbour underlying vascular m
alformations. We review 13 patients with a positive history of drug abuse p
receding the onset of intracerebral haemorrhage. These patients presented t
o the National Hospital for Neurology and Neurosurgery in central London ov
er a 7-month period. Of the 13 patients (eight male, five female), average
age 31 years (19-43) years), 10 were well enough to undergo cerebral angiog
raphy. Intracranial aneurysms were demonstrated in six patients and arterio
venous malformations in three patients. In only one of the patients was the
angiogram normal. A further patient was subsequently shown to have a middl
e cerebral artery aneurysm at autopsy. The epidemiology, pharmacology and s
ystemic effects of these drugs are considered. The mechanisms by which thes
e compounds cause intracerebral complications and their influence on progno
sis are discussed. The incidence of intracerebral haemorrhage (ICH), ischae
mic cerebral infarctions and subarachnoid haemorrhage (SAH) following drug
abuse is increasing. Contrary to historical opinion, drug-related ICH is fr
equently related to an underlying vascular malformation. Arteriography shou
ld be part of the evaluation of most young patients with nontraumatic ICH.
A thorough history focusing on the use of illicit substances and toxicologi
cal screening of urine and serum should be part of the evaluation of any yo
ung patient with a stroke.